Sodium-glucose cotransporter-2 inhibitors increase urinary tract infections?—a cross sectional analysis of a nationwide Japanese claims database

Sodium-glucose cotransporter-2 (SGLT2) inhibitors are a novel class of antidiabetic drugs. Guidelines for the proper use of SGLT2 inhibitors recommend caution regarding urinary tract infections (UTIs). However, little evidence has been reported on the relationship between SGLT2 inhibitors and UTIs i...

Full description

Bibliographic Details

Published in:	Endocrine Journal
Main Authors:	Go Anan, Daisuke Kikuchi, Kenji Omae, Takuo Hirose, Kouji Okada, Takefumi Mori
Format:	Article
Language:	English
Published:	The Japan Endocrine Society 2023-11-01
Subjects:	sodium-glucose cotransporter-2 inhibitor urinary tract infection epidemiological study diabetes mellitus
Online Access:	https://www.jstage.jst.go.jp/article/endocrj/70/11/70_EJ23-0317/_html/-char/en